2-chloromethyl-1-methylnaphthalene | 96437-13-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-chloromethyl-1-methylnaphthalene
• 英文别名: 2-(Chloromethyl)-1-methylnaphthalene
• CAS: 96437-13-7
• 化学式: C₁₂H₁₁Cl
• 分子量: 190.672
• InChiKey: HZODSUZFJLKBTE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  2-chloromethyl-1-methylnaphthalene 在 吡啶 、 氯化亚砜 、 盐酸羟胺 、 sodium methylate 作用下， 以 甲醇 、 二氯甲烷 、 水 、 二甲基亚砜 、 乙腈 为溶剂， 反应 20.92h， 生成 4-[(1-methyl-2-naphthalenyl)methyl]-3H-1,2,3,5-oxathiadiazole 2-oxide
  参考文献：
  名称：

  Antihyperglycemic activity of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides

  摘要：

  A series of naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides was prepared and tested for antihyperglycemic activity in the db/db mouse, a model for type 2 (non-insulin dependent) diabetes mellitus. Substitution at the 1-, 5-, or 8-positions of the naphthalene ring with a halogen was found to be beneficial to antihyperglycemic activity. 4-[(5-Chloronaphthalen-2-yl)methyl]-3H-1,2,3,5-oxathiadiazole 2-oxide (45), one of the most potent compounds in this series, was selected for further pharmacological evaluation.

  DOI：

  10.1021/jm00069a006
• 作为产物：
  描述：

  2-hydroxymethyl-1-methylnaphthalene 在 氯化亚砜 、 zinc(II) chloride 作用下， 以 1,4-二氧六环 为溶剂， 反应 0.67h， 生成 2-chloromethyl-1-methylnaphthalene
  参考文献：
  名称：

  Antihyperglycemic activity of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides

  摘要：

  A series of naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides was prepared and tested for antihyperglycemic activity in the db/db mouse, a model for type 2 (non-insulin dependent) diabetes mellitus. Substitution at the 1-, 5-, or 8-positions of the naphthalene ring with a halogen was found to be beneficial to antihyperglycemic activity. 4-[(5-Chloronaphthalen-2-yl)methyl]-3H-1,2,3,5-oxathiadiazole 2-oxide (45), one of the most potent compounds in this series, was selected for further pharmacological evaluation.

  DOI：

  10.1021/jm00069a006

文献信息

• Antidepressant imidazolines and related compounds
  申请人：Sterling Drug Inc.

  公开号：US04540705A1

  公开（公告）日：1985-09-10

  2-(2-Naphthalenyl)alkyl-4,5-dihydro-1H-imidazoles and -tetrahydropyrimidines, the corresponding 3,4-dihydronaphthalenyl and 1,2,3,4-tetrahydronaphthalenyl compounds; and the corresponding indene and indane derivatives, useful as antidepressant or diuretic agents, are prepared by reacting the appropriate 2-(cyanoalkyl)naphthalene or -indane derivative (or the corresponding ester or imino-ether) with an alkylenediamine.

  2-(2-萘基)烷基-4,5-二氢-1H-咪唑和-四氢嘧啶，相应的3,4-二氢萘基和1,2,3,4-四氢萘基化合物;以及相应的茚和茚烷衍生物，可用作抗抑郁或利尿剂，通过将适当的2-(氰基烷基)萘或茚衍生物（或相应的酯或亚胺醚）与烷基二胺反应制备。
• Imidazolines and related compounds and preparation thereof
  申请人：STERLING DRUG INC.

  公开号：EP0125410A2

  公开（公告）日：1984-11-21

  2-(2-Naphthalenyl)alkyl-4,5-dihydro-1H-imidazoles and -tetrahydropyrimidines, the corresponding 3,4-dihydro- naphthalenyl and 1,2,3,4-tetrahydronaphthalenyl compounds; and the corresponding indene and indane derivatives, having the Formulas 1, II or III herein, useful as antidepressant or diuretic agents, are prepared by reacting the appropriate 2-(cyanoalkyl)naphthalene or -indane derivative (or the corresponding ester or imino-ether) with an alkylenediamine to prepare a compound where Z is an alkylene bridge or reacting the cyanoalkyl compound with an aminoacetaidehy- de acetal to prepare a compound where Z is -CH=CH-.

  2-(2-萘基)烷基-4,5-二氢-1H-咪唑和四氢嘧啶，相应的3,4-二氢萘基和1,2,3,4-四氢萘基化合物；以及相应的茚和茚衍生物，具有本文式1、II或III，可用作抗抑郁剂或利尿剂，制备方法是将适当的2-(氰基烷基)萘或茚衍生物（或相应的酯或亚胺醚）与烷基二胺反应，制备Z为亚烷基桥的化合物，或将氰基烷基化合物与氨基乙酰胺缩醛反应，制备Z为-CH=CH-的化合物。
• Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions
  申请人：MERRELL DOW PHARMACEUTICALS INC.

  公开号：EP0381142A2

  公开（公告）日：1990-08-08

  This invention relates to the method of using aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds to treat interleukin-1 mediated conditions.

  本发明涉及使用芳基或杂芳基-1-烷基吡咯-2-羧酸化合物治疗白细胞介素-1介导的疾病的方法。
• Novel aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions
  申请人：MERRELL DOW PHARMACEUTICALS INC.

  公开号：EP0381141B1

  公开（公告）日：1996-03-20
• US4424394A
  申请人：——

  公开号：US4424394A

  公开（公告）日：1984-01-03